Peering Into Tonix Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Tonix Pharmaceuticals (NYSE:TNXP) has seen a significant rise in short interest, with a 3126.83% increase since its last report. The company now has 789 thousand shares sold short, representing 26.46% of its float. This high short interest could indicate bearish sentiment among investors.
June 24, 2024 | 4:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Tonix Pharmaceuticals has experienced a dramatic increase in short interest, now at 26.46% of its float. This could indicate bearish sentiment among investors, potentially leading to increased volatility in the stock price.
The significant rise in short interest suggests that many investors are betting against the stock, which could lead to downward pressure on the stock price. However, it could also result in a short squeeze if the stock price rises unexpectedly.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100